Skip to main content Skip to office menu Skip to footer
Capital IconMinnesota Legislature

SF 131

Status in the Senate for the 92nd Legislature (2021 - 2022)

Description

Drug manufacturers requirement to report and maintain prescription drug prices authorization; prescription drug formularies filing requirement; health carriers denying or limiting coverage due to lack of prior authorization prohibition; prescription benefit tool requirements establishment; prescription drug benefit transparency and disclosure requirement

Authors (3)

Actions

Senate

01/14/2021
Introduction and first reading
pg. 101 Intro
01/14/2021
03/09/2022
Author added Putnam
pg. 5263
03/28/2022
Author added Nelson
pg. 5659